These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18645680)

  • 1. Effect of testosterone on morphine withdrawal syndrome in rats.
    Nayebi AR; Rezazadeh H
    Asian J Androl; 2008 Sep; 10(5):765-9. PubMed ID: 18645680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of opiodergic system and testosterone on anxiety behavior in gonadectomized rats.
    Khakpai F
    Behav Brain Res; 2014 Apr; 263():9-15. PubMed ID: 24468308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence].
    Konstantinopol'skiĭ MA; Cherniakova IV
    Eksp Klin Farmakol; 2011; 74(10):12-6. PubMed ID: 22238980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD) reduces disinhibitory behavior in intact adult male rats treated with a high dose of testosterone.
    Svensson AI
    Behav Brain Res; 2010 Jan; 206(2):216-22. PubMed ID: 19766145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
    Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
    Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of morphine-induced dependence in gonadectomized male and female mice.
    Sadeghi M; Sianati S; Anaraki DK; Ghasemi M; Paydar MJ; Sharif B; Mehr SE; Dehpour AR
    Pharmacol Biochem Behav; 2009 Feb; 91(4):604-9. PubMed ID: 18930756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
    Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
    Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitated morphine withdrawal in rats as a tool in opiate research.
    Bläsig J; Herz A
    Curr Dev Psychopharmacol; 1977; 4():129-49. PubMed ID: 340143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the physical dependence on proline analog of dermorphin and morphine].
    Guzevatykh LS; Valuĭskikh DV; Voronina TA; Emel'ianova TG; Andreeva LA; Alfeeva LIu; Miasoedov NF
    Eksp Klin Farmakol; 2005; 68(3):16-9. PubMed ID: 16047673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal.
    Wang X; Liu Y; Lei Y; Zhou D; Fu Y; Che Y; Xu R; Yu H; Hu X; Ma Y
    Neurosci Lett; 2008 Mar; 433(3):178-82. PubMed ID: 18276072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of morphine-withdrawal body shakes by a conditional stimulus in the rat.
    Numan R; Smith N; Lal H
    Psychopharmacol Commun; 1975; 1(3):295-303. PubMed ID: 1241454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
    Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sweet tasting solutions on opioid withdrawal.
    Jain R; Mukherjee K; Singh R
    Brain Res Bull; 2004 Dec; 64(4):319-22. PubMed ID: 15561466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of testosterone on morphine analgesia in albino rats.
    Rao SS; Saifi AQ
    Indian J Physiol Pharmacol; 1985; 29(2):103-6. PubMed ID: 4093190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].
    Konstantinopol'skiĭ MA; Cherniakova IV; Kudrin VS; Klodt PM; Kolik LG; Gudasheva TA
    Eksp Klin Farmakol; 2013; 76(10):6-11. PubMed ID: 24400381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.